Parse Biosciences, a provider of scalable single-cell sequencing solutions, has secured $41.5 million in Series B funding.
Company Info
Company
Parse Biosciences
Additional Info
Parse Biosciences is providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease. Learn more about how you can use the most scalable single cell platform on the market without the need for custom instrumentation.
